These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21118180)

  • 1. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
    Partigulova AS; Naumov VG
    Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.
    Montecucco F; Pende A; Mach F
    Mediators Inflamm; 2009; 2009():752406. PubMed ID: 19390623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
    Fukui K; Yamada H; Matsubara H
    Nihon Rinsho; 2012 Sep; 70(9):1556-61. PubMed ID: 23012803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
    Ferrario CM; Strawn WB
    Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.
    Pende A; Montecucco F
    Curr Pharm Des; 2012; 18(7):950-1. PubMed ID: 22283769
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin-angiotensin system blockade: Its contribution and controversy.
    Miyajima A; Kosaka T; Kikuchi E; Oya M
    Int J Urol; 2015 Aug; 22(8):721-30. PubMed ID: 26032599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin-aldosterone system as a target in coronary disease.
    O'Keefe JH; Lurk JT; Kahatapitiya RC; Haskin JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):124-30. PubMed ID: 12573198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.
    Patarroyo Aponte MM; Francis GS
    Curr Cardiol Rep; 2012 Aug; 14(4):433-42. PubMed ID: 22562592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
    Stanton A
    Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin angiotensin system and ASCVD.
    Farmer JA
    Curr Opin Cardiol; 2000 May; 15(3):141-50. PubMed ID: 10952419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
    Hirata Y; Fukuda D; Sata M
    Nihon Rinsho; 2011 Jan; 69(1):55-9. PubMed ID: 21226261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
    Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue angiotensin generation and regulation of vascular tone.
    Cockcroft JR; O'Kane KP; Webb DJ
    Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin-angiotensin system in atherosclerosis].
    Fukuda D; Sata M
    Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation.
    Di Raimondo D; Tuttolomondo A; Buttà C; Miceli S; Licata G; Pinto A
    Curr Pharm Des; 2012; 18(28):4385-413. PubMed ID: 22283779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.